FDA's Woodcock Expresses Concern Not All Generics Are Equivalent, But OGD May Have Solution
It didn't seem like deliberate choice to play good cop-bad cop, but Acting Office of Generic Drugs Director Keith Webber and Center for Drug Evaluation and Research Director Janet Woodcock offered a near textbook version of it at the recent Generic Pharmaceutical Association Fall Technical Conference.
You may also be interested in...
Commissioner Scott Gottlieb and CDER Director Janet Woodcock say in joint statement that patients can be confident generics are safe and effective and recent media reports misinterpreted inspection and other data when suggesting the contrary.
A cluster of complaints in one area may inform a new safety signal or other problem, agency official says.
Sen. Cassidy does not think additional appropriations are needed for a massive provider and patient education on biosimilars.